Oral probiotics in coronavirus disease 2019: connecting the gut–lung axis to viral pathogenesis, inflammation, secondary infection and clinical trials

Defined as helpful live bacteria that can provide medical advantages to the host when administered in tolerable amounts, oral probiotics might be worth considering as a possible preventive or therapeutic modality to mitigate coronavirus disease 2019 (COVID-19) symptom severity. This hypothesis stems...

Descripción completa

Detalles Bibliográficos
Autores principales: Baindara, P., Chakraborty, R., Holliday, Z.M., Mandal, S.M., Schrum, A.G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785423/
https://www.ncbi.nlm.nih.gov/pubmed/33425362
http://dx.doi.org/10.1016/j.nmni.2021.100837

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785423/
https://www.ncbi.nlm.nih.gov/pubmed/33425362
http://dx.doi.org/10.1016/j.nmni.2021.100837

Ejemplares similares